Crocs, Inc.
NASDAQ:CROXApparel - Footwear & Accessories
+$1.47 today
- Market cap
- $7.44B
- Beta
- 1.56
- P/E (TTM)
- -61.1
- EPS (TTM)
- -$2.06
Volume 0.90M
Average 1.25M
CROX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Crocs, Inc.NASDAQ: CROX
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA grows, but more slowly than its trailing trend
Q3 FY2026 EBITDA of $296.49M rose 28.1% year over year, behind the +245.2% change in trailing-twelve-month EBITDA. Sequentially, it fell 3.5% from the prior quarter. Over 3 fiscal years it compounded at -35.4% a year.
Context
- EBITDA amounted to 6.0% of revenue in FY2025, down 20.6 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 10 analysts of $1.29B (+434.2%) for the fiscal year ending Dec 2026, a step up from the -77.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $296.49M-3.5% QoQ
- Last fiscal yearDec 2025
- $240.55M-77.9% YoY
- LTMSep 2026
- $992.75M+245.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +28.1% | +43.7% | +15.6 pp |
| 1 year | -77.9% | +434.2% | +512.1 pp |
| 3-year CAGR | -35.4% | +83.8% | +119.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 240.55M USD
- Year-over-year change
- -77.9%
- 4-year CAGR
- -23.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 240.55M | -77.9% |
| FY2024 | 2024-12-31 | 1.09B | -0.2% |
| FY2023 | 2023-12-31 | 1.09B | +22.2% |
| FY2022 | 2022-12-31 | 893.9M | +24.6% |
| FY2021 | 2021-12-31 | 717.47M | — |
EBITDA vs competitors
How CROX compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +245.2% is the highest of 11, against a peer median of +10.9%.
- EBITDA amounts to 24.2% of revenue for CROX, versus a peer median of 10.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $4.56B USD | -0.8% | -14.8% | 9.9% | |
| LTM Sep 2026 | $1.43B USD | +3.7% | +25.1% | 25.7% | |
| LTM Sep 2026 | $992.75M USD | +245.2% | -35.4% | 24.2% | |
| LTM Jun 2026 | €683.8M EUR | +9.1% | +16.7% | 29.9% | |
| LTM Sep 2026 | CHF 677.56M CHF | +84.7% | +40.2% | 20.1% | |
| LTM Jun 2026 | $256.25M USD | +60.1% | -26.3% | 9.4% | |
| LTM May 2026 | $129.95M USD | +60.0% | -22.9% | 4.5% | |
| LTM May 2026 | $83.28M USD | +17.6% | -19.6% | 3.4% | |
| LTM May 2026 | $55.85M USD | -65.3% | -36.5% | 2.0% | |
| LTM Mar 2026 | $51.76M USD | +12.7% | -5.9% | 10.5% | |
| LTM Mar 2026 | $35.83M USD | -12.7% | -6.9% | 13.0% | |
| Peer median (excluding CROX) | — | +10.9% | -10.8% | 10.2% | |
Competitors are the stored peer set for CROX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.31B | 3.55B | 3.96B | 4.1B | 4.04B |
| Cost of Revenue | 893.2M | 1.69B | 1.78B | 1.69B | 1.68B |
| Gross Profit | 1.42B | 1.86B | 2.18B | 2.41B | 2.36B |
| Gross Margin | 61.4% | 52.3% | 55.0% | 58.8% | 58.3% |
| Research & Development | 13.7M | 18.7M | 21.4M | 25.6M | 29.6M |
| Selling, General & Admin | 715.89M | 929.16M | 1.11B | 1.29B | 1.44B |
| Operating Expenses | 737.16M | 1.01B | 1.13B | 1.39B | 2.21B |
| Depreciation & Amortization | 31.98M | 39.23M | 54.3M | 69.84M | 79.28M |
| EBITDA | 717.47M | 893.9M | 1.09B | 1.09B | 240.55M |
| EBITDA Margin | 31.0% | 25.1% | 27.6% | 26.6% | 6.0% |
| Operating Income | 683.06M | 850.76M | 1.05B | 1.02B | 149.52M |
| Operating Margin | 29.5% | 23.9% | 26.4% | 24.9% | 3.7% |
| Interest Income | 775K | 1.02M | 2.41M | 3.48M | 1.84M |
| Interest Expense | 21.65M | 136.16M | 161.35M | 109.26M | 88.29M |
| Other Income / Expenses | (19.22M) | (132.25M) | (170.2M) | (111.33M) | (76.54M) |
| Income Before Tax | 663.85M | 718.51M | 876.27M | 910.59M | 72.98M |
| Pre-Tax Margin | 28.7% | 20.2% | 22.1% | 22.2% | 1.8% |
| Income Tax Expense | (61.85M) | 178.35M | 83.71M | (39.49M) | 154.18M |
| Net Income | 725.69M | 540.16M | 792.57M | 950.07M | (81.2M) |
| Net Margin | 31.4% | 15.2% | 20.0% | 23.2% | -2.0% |
| EPS (Basic) | 11.62 | 8.82 | 12.91 | 16.00 | (1.50) |
| EPS (Diluted) | 11.39 | 8.71 | 12.79 | 15.88 | (1.50) |
| Weighted Avg Shares | 62.46M | 61.22M | 61.39M | 59.38M | 54.21M |
| Weighted Avg Shares (Diluted) | 63.72M | 62.01M | 61.95M | 59.83M | 54.21M |
Crocs, Inc.
NASDAQ:CROX
Intrinsic Alpha fair value
Locked
Current Price
$162.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.